Sai Life

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE570L01029
  • NSEID: SAILIFE
  • BSEID: 544306
INR
1,127.15
1.75 (0.16%)
BSENSE

May 20

BSE+NSE Vol: 1.1 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039479,
    "name": "Sai Life",
    "stock_name": "Sai Life",
    "full_name": "Sai Life Sciences Ltd",
    "name_url": "stocks-analysis/sai-life",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,127.15",
    "chg": 1.75,
    "chgp": "0.16%",
    "dir": 1,
    "prev_price": "1,125.40",
    "mcapval": "23,912.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544306,
    "symbol": "SAILIFE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE570L01029",
    "curr_date": "May 20",
    "curr_time": "",
    "bse_nse_vol": "1.1 lacs",
    "exc_status": "Active",
    "traded_date": "May 20, 2026",
    "traded_date_str": "2026 05 20",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sai-life-10039479-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sai Life Sciences Ltd is Rated Buy by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sai-life-sciences-ltd-is-rated-buy-by-marketsmojo-3998837",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SaiLifeSciences_mojoScore_3998837.png",
        "date": "2026-05-19 10:10:44",
        "description": "Sai Life Sciences Ltd is rated Buy by MarketsMOJO, with this rating last updated on 02 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 May 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Sai Life Sciences Ltd to 52-Week High of Rs 1146",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sai-life-sciences-ltd-hits-new-52-week-high-of-rs-1146-on-19-may-2026-3998583",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SaiLifeSciences_priceRelatedfactors_3998583.png",
        "date": "2026-05-19 09:41:27",
        "description": "With a robust rally that has propelled Sai Life Sciences Ltd to a fresh 52-week high of Rs 1146, the stock has outpaced the broader market by a wide margin, delivering a 48.47% gain over the past year compared to the Sensex’s decline of 7.95%. This milestone underscores the strong momentum underpinning the stock’s price action amid mixed market conditions."
      },
      {
        "title": "Are Sai Life Sciences Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-sai-life-sciences-ltd-latest-results-good-or-bad-3995067",
        "imagepath": "",
        "date": "2026-05-16 19:31:50",
        "description": "Sai Life Sciences Ltd's latest results for Q4 FY26 reflect a complex operational landscape. The company reported net sales of ₹602.14 crores, marking an 8.21% quarter-on-quarter increase and a modest 3.91% year-on-year growth. This achievement represents the highest quarterly sales figure in the company's history, indicating strong business momentum.\n\nHowever, the financial performance also highlighted challenges in profitability. The operating margin, excluding other income, contracted significantly to 29.32%, down from 33.76% in the previous quarter, raising concerns about margin sustainability amid competitive pressures. Despite this contraction, the year-on-year comparison shows an improvement from 27.19%, suggesting longer-term positive trends in operational efficiency.\n\nNet profit for the quarter reached ₹104.24 crores, reflecting an 18.09% increase year-on-year but only a 3.85% rise sequentially. The..."
      },
      {
        "title": "Sai Life Sciences Ltd Declines 2.47% Despite Early Highs: 6 Key Factors Shaping the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sai-life-sciences-ltd-declines-247-despite-early-highs-6-key-factors-shaping-the-week-3993760",
        "imagepath": "",
        "date": "2026-05-16 10:00:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>11 May:</strong> Sai Life Sciences Ltd hits new 52-week and all-time high at Rs.1,130.10</p>\n                    <p><strong>12 May:</strong> Stock declines sharply by 3.97% amid broader market weakness</p>\n                    <p><strong>14 May:</strong> Strong rebound with a 2.42% gain on heavy volume</p>\n                    <p><strong>15 May:</strong> Significant gap down and intraday low at Rs.977.35 amid volatility</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,116.85</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">We..."
      },
      {
        "title": "Sai Life Sciences Q4 FY26: Strong Finish Masks Margin Pressure Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/sai-life-sciences-q4-fy26-strong-finish-masks-margin-pressure-concerns-3993419",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SaiLifeSciences_quaterlyResult_3993419.png",
        "date": "2026-05-15 17:21:00",
        "description": "Sai Life Sciences Limited, the contract research and manufacturing services provider, reported a net profit of ₹104.24 crores for Q4 FY26, marking an 18.09% year-on-year increase but a modest 3.85% sequential growth from the previous quarter. The pharmaceutical services company, with a market capitalisation of ₹20,670 crores, delivered mixed signals as revenue growth accelerated whilst operating margins contracted sharply on a sequential basis."
      },
      {
        "title": "Sai Life Sciences Ltd Reports Robust Quarterly Growth Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sai-life-sciences-ltd-reports-robust-quarterly-growth-amid-market-volatility-3992750",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SaiLifeSciences_fintrenddot_3992750.png",
        "date": "2026-05-15 11:00:38",
        "description": "Sai Life Sciences Ltd has delivered a strong quarterly performance for the period ending March 2026, showcasing significant revenue growth and margin expansion despite a recent dip in its financial trend score. The company’s latest results highlight resilience in a challenging market environment, with key profitability metrics reaching record highs and an upgraded investment grade signalling renewed investor confidence."
      },
      {
        "title": "Sai Life Sciences Ltd Opens 5.76% Lower in Sharp Gap Down as Technicals Point to Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sai-life-sciences-ltd-opens-with-significant-gap-down-amid-market-concerns-3992251",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SaiLifeSciences_gapdown_3992251.png",
        "date": "2026-05-15 09:35:35",
        "description": ""
      },
      {
        "title": "Sai Life Sciences Ltd Hits Intraday Low Amid Price Pressure on 15 May 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sai-life-sciences-ltd-hits-intraday-low-amid-price-pressure-on-15-may-2026-3992221",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SaiLifeSciences_priceRelatedfactors_3992221.png",
        "date": "2026-05-15 09:31:23",
        "description": "Sai Life Sciences Ltd experienced a significant intraday decline on 15 May 2026, with the stock touching a low of Rs 977.35, down 12.2% from its previous close. The pharmaceutical company underperformed its sector and the broader market, reflecting immediate price pressures and heightened volatility despite a generally positive market environment."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Sai Life Sciences Ltd to 52-Week High of Rs 1130.1",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sai-life-sciences-ltd-hits-new-52-week-high-at-rs11301-3985153",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SaiLifeSciences_priceRelatedfactors_3985153.png",
        "date": "2026-05-11 09:47:34",
        "description": "With a sustained rally that has pushed Sai Life Sciences Ltd to a fresh 52-week high of Rs 1130.1 on 11 May 2026, the stock’s momentum is underpinned by a confluence of bullish technical indicators and robust price action, even as the broader market trades lower."
      }
    ],
    "total": 192,
    "sid": "10039479",
    "stock_news_url": "https://www.marketsmojo.com/news/sai-life-sciences-10039479"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "16-May-2026",
      "details": "Newspaper publication for the Audited Financial Results for the quarter and year ended 31 March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "15-May-2026",
      "details": "Allotment of 92000 Equity Shares under ESOP Schemes of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "15-May-2026",
      "details": "Investor Presentation for the quarter and year ended 31 March 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Sai Life Sciences Ltd Declines 2.47% Despite Early Highs: 6 Key Factors Shaping the Week

2026-05-16 10:00:04

Key Events This Week

11 May: Sai Life Sciences Ltd hits new 52-week and all-time high at Rs.1,130.10

12 May: Stock declines sharply by 3.97% amid broader market weakness

14 May: Strong rebound with a 2.42% gain on heavy volume

15 May: Significant gap down and intraday low at Rs.977.35 amid volatility

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

16-May-2026 | Source : BSE

Newspaper publication for the Audited Financial Results for the quarter and year ended 31 March 2026.

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

15-May-2026 | Source : BSE

Allotment of 92000 Equity Shares under ESOP Schemes of the Company.

Announcement under Regulation 30 (LODR)-Investor Presentation

15-May-2026 | Source : BSE

Investor Presentation for the quarter and year ended 31 March 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available